Edition:
United States

Celesio AG (CLSGn.DE)

CLSGn.DE on Xetra

25.79EUR
11:36am EDT
Change (% chg)

€-0.01 (-0.04%)
Prev Close
€25.80
Open
€25.84
Day's High
€25.90
Day's Low
€25.64
Volume
40,587
Avg. Vol
71,370
52-wk High
€25.98
52-wk Low
€24.33

CLSGn.DE

Chart for CLSGn.DE

About

Celesio AG is a Germany-based trading company and provider of logistics and services in the pharmaceutical and healthcare sector. It operates through two business divisions, namely Patient and Consumer Solutions, as well as Pharmacy Solutions. The Patient and Consumer Solutions division is aimed at patients and consumers, and... (more)

Overall

Beta: 0.60
Market Cap(Mil.): €5,243.10
Shares Outstanding(Mil.): 203.22
Dividend: 0.83
Yield (%): 3.22

Financials

  CLSGn.DE Industry Sector
P/E (TTM): 10.82 20.96 44.21
EPS (TTM): 2.38 -- --
ROI: -- 12.33 66.60
ROE: -- 14.05 77.10

BRIEF-CMA gives Celesio pharmacy merger plans conditional approval

* Competition and Markets Authority gives pharmacy merger conditional go-ahead.

Jul 29 2016

BRIEF-Celesio FY 2016 group revenue at 21,414.2 mln euros

* Generated group revenue of 21,414.2 million euros ($23.90 billion) in fiscal 2016, which is up 3.7 percent on the fiscal year 2014

Jun 24 2016

BRIEF-Celesio: Brocacef Group acquisition of Mediq Apotheken Nederland approved by ACM

* Brocacef Groep NV, a joint venture of the Phoenix Group and Celesio AG, has received approval from the Dutch Authority For Consumers & Markets (ACM) to acquire Mediq Apotheken Nederland BV

Jun 14 2016

BRIEF-PCB announces possible takeover bid from Celesio

* Possible capital increase and public takeover bid, subject to the closing of the acquisition of Belmedis

May 25 2016

BRIEF-UK regulator says pharmacy sales could resolve Sainsbury's/Celesio deal

April 29 UK Competition and Markets Authority (CMA)

Apr 29 2016

BRIEF-Celesio to acquire Holon in Portugal

* Purchase price was not disclosed Source text - http://bit.ly/1RObpyS Further company coverage: (Gdynia Newsroom)

Apr 11 2016

Earnings vs. Estimates